RxDoctor Payments Data

Michael Brewer, OD

Optometrist · Bay City, MINPI 1629081708

Payments from drug & device makers

$3,312in general payments, 2019–2025

Across 82 payments — averaging $40.39 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Biotissue Holdings Inc.$2K
  • The Walman Optical Company$480
  • Bausch & Lomb Americas Inc.$294
  • Tarsus Pharmaceuticals, Inc.$224
  • Alcon$136
  • Dompe US, Inc.$124
  • plus $496 from 12 others

What the payments were for

  • Travel & lodging$1,14635%
  • Food & beverage$1,68651%
  • Gifts$48014%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$3,312 in reported general payments places this provider in the 90th percentile of 1,523 optometrist providers in Michigan.

See all optometrist providers in Michigan

Medicare billing

Part B allowed, 2024
$70,929
Medicare patients
410
Services billed
693

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Cyclosporine78$49,745
RestasisCyclosporine26$37,856
MieboPerfluorohexyloctane/Pf13$9,054
Brimonidine Tartrate57$6,310
Latanoprost179$3,179
Neomycin-Polymyxin-DexamethNeomycin/Polymyxin B/Dexametha52$661
Prednisolone Acetate22$637
Timolol Maleate17$131
Ofloxacin11$106

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AbbVieRestasis$34$37,85626 claims
Bausch & Lomb Americas Inc.Miebo$294$9,05413 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 1,523 optometrist providers in Michigan.

Other optometrist in Bay City

See the full list for Michigan

Where these figures come from

Is this you, or does something look wrong? →